Haoxiangni Health Food Co., Ltd. (002582.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.4B	1.3B	1.6B	1.7B	1.4B
Cost of Revenue	993.2M	940.8M	1.3B	1.3B	1.1B
Gross Profit	429.8M	387.0M	377.9M	444.8M	319.2M
Operating Expenses
R&D Expense	19.0M	19.8M	20.6M	28.6M	38.7M
SG&A Expense	—	—	—	—	—
General & Admin Expense	109.5M	106.5M	112.5M	131.3M	117.5M
Selling & Marketing Expense	314.1M	292.5M	349.4M	364.2M	315.6M
Other Expenses	—	—	—	—	—
Total Operating Expenses	457.0M	430.7M	483.3M	510.6M	447.6M
Cost and Expenses	1.5B	1.4B	1.7B	1.8B	1.5B
Operating Income (EBIT)	2.6B	1.1B	(72.0M)	(49.7M)	(230.8M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	2.6B	1.1B	(75.4M)	(50.8M)	(234.2M)
Income Tax Expense	631.6M	278.7M	272.4K	5.8M	(31.3M)
Bottom Line
Net Income	1.9B	866.1M	(72.0M)	(51.9M)	(189.4M)
Earnings from Cont. Ops	885.1M	865.2M	(75.7M)	(56.5M)	(202.9M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	1.9B	866.1M	(72.0M)	(51.9M)	(189.4M)
Per Share
Basic EPS	CN¥4.39	CN¥2.00	(CN¥0.16)	(CN¥0.12)	(CN¥0.43)
Diluted EPS	CN¥4.39	CN¥2.00	(CN¥0.16)	(CN¥0.12)	(CN¥0.43)
Revenue Per Share	CN¥3.18	CN¥3.07	CN¥3.65	CN¥4.00	CN¥3.18
Shares
Basic Shares Outstanding	448.0M	433.0M	449.7M	432.4M	440.5M
Diluted Shares Outstanding	448.0M	433.0M	449.7M	432.4M	440.5M
Profitability Metrics
EBITDA	—	1.3B	59.8M	80.0M	(94.1M)
D&A	—	135.9M	131.8M	129.8M	136.6M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026